HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Aurora Astudillo Selected Research

RNA (Ribonucleic Acid)

2/2017Clinically relevant HIF-1α-dependent metabolic reprogramming in oropharyngeal squamous cell carcinomas includes coordinated activation of CAIX and the miR-210/ISCU signaling axis, but not MCT1 and MCT4 upregulation.
10/2015Heparan sulfate proteoglycans undergo differential expression alterations in right sided colorectal cancer, depending on their metastatic character.
8/2009Cystatin D is a candidate tumor suppressor gene induced by vitamin D in human colon cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Aurora Astudillo Research Topics

Disease

47Neoplasms (Cancer)
01/2023 - 11/2003
10Squamous Cell Carcinoma of Head and Neck
09/2022 - 08/2012
8Carcinoma (Carcinomatosis)
09/2022 - 09/2007
8Neoplasm Metastasis (Metastasis)
01/2022 - 09/2007
6Sarcoma (Soft Tissue Sarcoma)
03/2024 - 06/2004
6Inflammation (Inflammations)
09/2022 - 08/2007
6Ventilator-Induced Lung Injury
01/2018 - 03/2008
6Colorectal Neoplasms (Colorectal Cancer)
10/2015 - 06/2009
5Hypoxia (Hypoxemia)
06/2022 - 01/2017
5Paraganglioma (Paragangliomas)
01/2019 - 11/2012
4Lung Neoplasms (Lung Cancer)
01/2022 - 05/2011
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2021 - 05/2007
4Lung Injury
01/2018 - 11/2008
4Colonic Neoplasms (Colon Cancer)
08/2015 - 08/2009
3Glioblastoma (Glioblastoma Multiforme)
01/2021 - 05/2018
3Alzheimer Disease (Alzheimer's Disease)
05/2019 - 12/2003
3Multiple Sclerosis
01/2018 - 04/2008
3Lymphatic Metastasis
10/2015 - 05/2007
3Disease Progression
11/2014 - 08/2012
2Melanoma (Melanoma, Malignant)
01/2022 - 03/2013
2Glioma (Gliomas)
01/2020 - 01/2018
2Infections
01/2020 - 03/2009
2Laryngeal Neoplasms (Laryngeal Cancer)
01/2018 - 11/2017
2Carcinogenesis
01/2018 - 05/2011
2Myxoid Liposarcoma
01/2018 - 06/2017
2Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2018 - 04/2008
2Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2016 - 01/2014
2Endotoxemia
06/2014 - 01/2012
2Breast Neoplasms (Breast Cancer)
01/2013 - 06/2007
2Neurodegenerative Diseases (Neurodegenerative Disease)
03/2010 - 01/2008
2Skin Neoplasms (Skin Cancer)
08/2007 - 06/2004
2Pneumococcal Pneumonia
01/2007 - 08/2004
1Chondrosarcoma
03/2024
1Chromosome Aberrations (Chromosome Abnormalities)
12/2022
1Thyroid Nodule (Nodule, Thyroid)
09/2022
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2020
1Pheochromocytoma
01/2019

Drug/Important Bio-Agent (IBA)

18Proteins (Proteins, Gene)FDA Link
01/2021 - 06/2004
11EnzymesIBA
01/2020 - 06/2004
9DNA (Deoxyribonucleic Acid)IBA
09/2022 - 03/2009
8Biomarkers (Surrogate Marker)IBA
11/2019 - 08/2012
7Matrix Metalloproteinases (MMPs)IBA
10/2011 - 11/2003
5Messenger RNA (mRNA)IBA
01/2023 - 01/2013
5Matrix Metalloproteinase 8 (Neutrophil Collagenase)IBA
01/2018 - 11/2003
5Cadherins (E-Cadherin)IBA
11/2014 - 08/2009
5Peptide Hydrolases (Proteases)FDA Link
11/2013 - 11/2003
4CateninsIBA
09/2022 - 01/2013
4IronIBA
05/2019 - 09/2008
4Succinate Dehydrogenase (Fumarate Reductase)IBA
01/2019 - 10/2013
4Apolipoproteins D (Apo D)IBA
01/2018 - 12/2003
4MicroRNAs (MicroRNA)IBA
02/2017 - 11/2012
3Cyclin-Dependent Kinase Inhibitor p16IBA
04/2019 - 03/2013
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2019 - 05/2016
3sulofenur (ISCU)IBA
01/2018 - 11/2012
3RNA (Ribonucleic Acid)IBA
02/2017 - 08/2009
3Proteoglycans (Proteoglycan)IBA
10/2015 - 01/2013
3GlycosaminoglycansIBA
10/2015 - 01/2013
3ParaffinIBA
12/2014 - 05/2007
3LigandsIBA
04/2013 - 04/2008
3Tyrosine Kinase InhibitorsIBA
03/2013 - 06/2004
3CytokinesIBA
12/2012 - 06/2007
3Matrix Metalloproteinase 9 (Gelatinase B)IBA
03/2008 - 06/2007
2B7-H1 AntigenIBA
01/2023 - 04/2021
2Monoclonal AntibodiesIBA
01/2022 - 08/2004
2ChromatinIBA
01/2021 - 01/2018
25-hydroxymethylcytosineIBA
01/2020 - 01/2018
2Phosphotransferases (Kinase)IBA
01/2019 - 01/2018
2SulfurIBA
01/2018 - 11/2012
2Lamin Type A (Lamin A)IBA
01/2018 - 05/2002
2Small Interfering RNA (siRNA)IBA
01/2018 - 01/2017
2heparanaseIBA
01/2016 - 01/2013
2Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA
10/2015 - 01/2013
2GlypicansIBA
10/2015 - 01/2014
2Superoxide DismutaseIBA
08/2015 - 10/2009
2micaIBA
04/2013 - 04/2008
2Imatinib Mesylate (Gleevec)FDA Link
03/2013 - 06/2004
2Metalloproteases (Metalloproteinases)IBA
09/2009 - 06/2009
2Streptococcus pneumoniae plY proteinIBA
01/2007 - 08/2004
1Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
03/2024
1enasidenibIBA
03/2024
1Mitomycin (Mitomycin-C)FDA LinkGeneric
12/2022
1Complement System Proteins (Complement)IBA
09/2022
1Oxygen (Dioxygen)IBA
06/2022
1CholesterolIBA
01/2022
1Histone MethyltransferasesIBA
01/2021
1Cyclin D1IBA
11/2020
1AminopeptidasesIBA
01/2020
1metal transporting protein 1 (ferroportin)IBA
05/2019
1isocitric acid (isocitrate)IBA
04/2019
1Histones (Histone)IBA
05/2018
1CortactinIBA
01/2018

Therapy/Procedure

8Therapeutics
03/2024 - 02/2008
5Artificial Respiration (Mechanical Ventilation)
01/2022 - 05/2013
2Drug Therapy (Chemotherapy)
04/2021 - 01/2021
2Positive-Pressure Respiration (Positive End-Expiratory Pressure)
01/2018 - 10/2011
1Precision Medicine
03/2024
1Immunotherapy
01/2023
1Thyroidectomy
09/2022
1Induction Chemotherapy
04/2021
1Laser Therapy (Surgery, Laser)
05/2019